Drug Profile
Porfiromycin
Alternative Names: ENT 50825; Methyl mitomycin C; NSC 56410; Porfiromycine; Porphyromycin; PromycinLatest Information Update: 31 Dec 2000
Price :
$50
*
At a glance
- Originator Yale University
- Developer Vion Pharmaceuticals
- Class Antineoplastics; Mitomycins; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Head and neck cancer